HCP Plastene Bulkpack Ltd (HPBL) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of HCP Plastene Bulkpack Ltd stock ₹379, price ₹297, upside +27.7%, quality 56 out of 100. Rating: undervalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.
How to read this chart
60‑month range ₹12.69 – ₹1,219 · fair‑value band ₹263.87 – ₹498.82 · the ₹296.80 price screens below the ₹379.03 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.
Follow HCP Plastene Bulkpack in your weekly email
Every Wednesday you see whether HCP Plastene Bulkpack is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
HCP Plastene Bulkpack Ltd (HPBL) currently trades at ₹296.80, while our model-based Fair Value estimate is ₹379.03, implying the stock looks roughly 22% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹935.83 per share, and 10 of the 14 models we run sit above the ₹296.80 price.
Bear case: the Asset-Based group reads lowest at ₹50.46, and 4 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹263.87 (bear) to ₹498.82 (bull), the price of ₹296.80 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 56/100 (solid quality), in the Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
HCP Plastene Bulkpack Ltd reported revenue of ₹5.9B in FY2026 versus ₹1.1B in FY2022, a compound +51.6%/yr. Reported net income was ₹232M in FY2026.
Key figures
Market cap ₹3.2B (≈ $33.7M) Micro · P/E ratio 8.0 · P/S ratio 0.50 · EPS (TTM) ₹37.25 · Net margin 5.2% · Return on equity 30.9% · Return on assets (EBIT) 6.4% (5-year average) · Operating margin 17.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 59 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 104% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Materials peers we cover trades at −5% fair-value upside, at 28%, HPBL screens cheaper than that median.
Fair Value models
Bear₹263.87Fair Value ₹379.03Bull₹498.82
Price ₹296.80 · Upside +27.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (₹22.76 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+26.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+106.5%
Start year 2021 (pandemic)
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−19.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−19.0%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−35% → 8%
Compare HCP Plastene Bulkpack Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Containers & Packaging · 23 stocks
Beats the industry median on 8/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score56 · Below median
Fair Value upside+27.7% · Top 25%
Profitability
Return on equity (12 months)30.9% · Top 25%
Return on assets6.1% · Above median
Net margin (12 months)5.2% · Below median
Operating margin (12 months)17.8% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)38.5% · Above median
Balance sheet
Debt / equity0.67× · Highest 25%
Valuation Multiplesvs Containers & Packaging median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is HCP Plastene Bulkpack Ltd (HPBL) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of ₹379.03 versus a price of ₹296.80, about +28% upside (undervalued).
What is the fair value of HPBL?
Our model-based fair value for HCP Plastene Bulkpack Ltd is ₹379.03 (as of Nov 3, 2026), built from audited fundamentals. The current price: ₹296.80.
What is the quality score of HPBL?
HCP Plastene Bulkpack Ltd has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HCP Plastene Bulkpack Ltd (HPBL)?
Our model-based price target is the fair value of ₹379.03 (as of Nov 3, 2026) from 14 valuation models. Cautious scenario ₹263.87, optimistic scenario ₹498.82. It is a calculation from audited fundamentals, not an analyst target.
What is the HCP Plastene Bulkpack Ltd stock forecast for 2026?
Our models put fair value at ₹379.03, about +28% upside versus a price of ₹296.80 (undervalued). Cautious scenario ₹263.87, optimistic scenario ₹498.82. The calculation is refreshed regularly with new filings.
What is the revenue of HCP Plastene Bulkpack Ltd (HPBL)?
HCP Plastene Bulkpack Ltd reported trailing-twelve-month revenue of about ₹6.4B (latest available figure, as of Nov 3, 2026).
What is the intrinsic value of HCP Plastene Bulkpack Ltd (HPBL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HCP Plastene Bulkpack Ltd it is ₹379.03 per share (as of Nov 3, 2026), against a price of ₹296.80. It is the blended result of 14 valuation models in 5 families (Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is HCP Plastene Bulkpack Ltd stock overvalued or undervalued in 2026?
As of Nov 3, 2026, HPBL trades below its calculated fair value: price ₹296.80, fair value ₹379.03, a gap of about +28% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HPBL?
No. The price is what the market pays today (₹296.80); the fair value is what the company's own numbers justify (₹379.03). For HCP Plastene Bulkpack Ltd the two are ₹82.23 per share apart. That gap is exactly why we show both numbers side by side.
How much is HCP Plastene Bulkpack Ltd worth?
The market values HCP Plastene Bulkpack Ltd at about ₹3.2B (market capitalisation, as of Nov 3, 2026). Per share that is ₹296.80; our models calculate a fair value of ₹379.03 per share.
What do the bullish and bearish scenarios say about HPBL?
Our models span a range for HCP Plastene Bulkpack Ltd: cautious scenario ₹263.87, base ₹379.03, optimistic ₹498.82 per share (as of Nov 3, 2026, price ₹296.80). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of HPBL?
HCP Plastene Bulkpack Ltd trades at a price-to-earnings ratio of 8.0 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹379.03 is built from several models across several years. Other multiples: PEG 1.0, P/B 3.9, P/S 0.5, EV/EBITDA 4.5.
What is the PEG ratio of HPBL?
The PEG ratio of HCP Plastene Bulkpack Ltd is 1.04 (P/E divided by earnings growth, as of Nov 3, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of HCP Plastene Bulkpack Ltd (HPBL)?
Balance-sheet figures for HCP Plastene Bulkpack Ltd (as of Nov 3, 2026): return on equity 30.9%, debt of 0.67 per unit of equity. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is HPBL from its 52-week high?
HCP Plastene Bulkpack Ltd trades at ₹296.80, about 26% below its 52-week high of ₹401.90 and 104% above the low of ₹145.50 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ₹379.03 is for.
Which stocks are comparable to HCP Plastene Bulkpack Ltd?
From the same area (Materials) we also value DAIOS, Daelim Paper Co, M2N Co, RDBRL, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HCP Plastene Bulkpack Ltd stock attractive at the current price?
The data as of Nov 3, 2026: price ₹296.80, calculated fair value ₹379.03 (+28%), Quality Score 56/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HPBL calculated?
We run HCP Plastene Bulkpack Ltd through 14 models from 5 families: Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹379.03 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. HCP Plastene Bulkpack Ltd currently trades 22% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HCP Plastene Bulkpack Ltd (HPBL)?
The closing price on Nov 6, 2026 was ₹296.80. Our model-based fair value is ₹379.03, about +28% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HCP Plastene Bulkpack Ltd right now?
Solid quality (56/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (₹263.87 to ₹498.82) leaves room in how you read the outcome.
Key figures of HCP Plastene Bulkpack Ltd
How large is the market capitalisation of HCP Plastene Bulkpack Ltd (HPBL)?
The market capitalisation of HCP Plastene Bulkpack Ltd is ₹3.2B (≈ $33.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HCP Plastene Bulkpack Ltd (HPBL)?
The price-to-sales ratio of HCP Plastene Bulkpack Ltd is 0.50 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of HCP Plastene Bulkpack Ltd (HPBL)?
Earnings per share at HCP Plastene Bulkpack Ltd are ₹37.25 (price ÷ EPS = P/E 8.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of HCP Plastene Bulkpack Ltd (HPBL)?
The net margin of HCP Plastene Bulkpack Ltd is 5.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HCP Plastene Bulkpack Ltd (HPBL)?
The return on equity (ROE) of HCP Plastene Bulkpack Ltd is 30.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HCP Plastene Bulkpack Ltd (HPBL)?
On an EBIT basis the return on assets of HCP Plastene Bulkpack Ltd is 6.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HCP Plastene Bulkpack Ltd (HPBL)?
The operating margin of HCP Plastene Bulkpack Ltd is 17.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HCP Plastene Bulkpack Ltd (HPBL)?
Revenue at HCP Plastene Bulkpack Ltd is growing +38.5% versus a year earlier (3y avg +18.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at HCP Plastene Bulkpack Ltd (HPBL)?
Earnings per share at HCP Plastene Bulkpack Ltd are growing +64.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does HCP Plastene Bulkpack Ltd (HPBL) generate?
The free cash flow of HCP Plastene Bulkpack Ltd is −₹190M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does HCP Plastene Bulkpack Ltd (HPBL) carry?
The net debt of HCP Plastene Bulkpack Ltd is ₹2.3B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch HCP Plastene Bulkpack Ltd in the live analysis
One click puts HCP Plastene Bulkpack Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 3, 2026